Lifeboat Foundation

Researchers have created chip-based photonic resonators that operate in the ultraviolet (UV) and visible regions of the spectrum and exhibit a record low UV light loss. The new resonators lay the groundwork for increasing the size, complexity and fidelity of UV photonic integrated circuit (PIC) design, which could enable new miniature chip-based devices for applications such as spectroscopic sensing, underwater communication and quantum information processing.

“Compared to the better-established fields like telecom photonics and visible photonics, UV photonics is less explored even though UV wavelengths are needed to access certain atomic transitions in atom/ion-based quantum computing and to excite certain fluorescent molecules for biochemical sensing,” said research team member Chengxing He from Yale University. “Our work sets a good basis toward building photonic circuits that operate at UV wavelengths.”

In Optics Express, the researchers describe the alumina-based optical microresonators and how they achieved an unprecedented low loss at UV wavelengths by combining the right material with optimized design and fabrication.

The search for definitive biosignatures—unambiguous markers of past or present life—is a central goal of paleobiology and astrobiology. We used pyrolysis–gas chromatography coupled to mass spectrometry to analyze chemically disparate samples, including living cells, geologically processed fossil organic material, carbon-rich meteorites, and laboratory-synthesized organic compounds and mixtures. Data from each sample were employed as training and test subsets for machine-learning methods, which resulted in a model that can identify the biogenicity of both contemporary and ancient geologically processed samples with ~90% accuracy. These machine-learning methods do not rely on precise compound identification: Rather, the relational aspects of chromatographic and mass peaks provide the needed information, which underscores this method’s utility for detecting alien biology.

Call it the big bang for bug-sized robots.

Cornell researchers combined soft microactuators with high-energy-density chemical fuel to create an insect-scale quadrupedal robot that is powered by combustion and can outrace, outlift, outflex and outleap its electric-driven competitors.

Computer performance is measured in FLOPS, or floating-point operations per second. The first supercomputer, which was developed in 1964, could run 3,000,000 FLOPS, i.e., 3 megaFLOPS. Exa means 18 zeros, meaning 1,000,000,000,000,000,000 FLOPS. An exascale computer can perform that many operations — something that is almost impossible to imagine.

Now, there is a huge advantage to commanding that kind of computing power in today’s world. Here is what the same McKinsey report says: “Exascale computing could allow scientists to solve problems that have until now been impossible. With exascale, exponential increases in memory, storage, and compute power may drive breakthroughs in several industries: energy production, storage, transmission, materials science, heavy industry, chemical design, AI and machine learning, cancer research and treatment, earthquake risk assessment, and many more.”

Put simply, China now may have the computing power at its disposal to match, or even overtake, technology leaders like the United States in several areas that could be key to becoming the dominant economic and military power in the world. China could also pair its advances in artificial intelligence with this mind-boggling computering power and achieve technological and military dominance quite quickly.

There are many therapies that target cancer. The most well-known is chemotherapy, which is a toxic chemical that is directed at a tumor to kill the cells. This is currently the standard of care for most types of cancer. However, as science advances, less toxic and more direct therapies are discovered. The most recently discovered therapy is known as ‘immunotherapy’, which redirects the immune system to kill the tumor. There are many successful treatments with immunotherapy among different types of cancers, including melanoma and lung cancer. Unfortunately, immunotherapy is limited in many solid tumors due to the immunosuppressive tumor microenvironment (TME). The TME is a pro-tumor environment that the cancer has made by releasing specific proteins that allow it to progress. In this environment the tumor can remain undetected from the immune system and progress throughout the body. Different immune cells in the TME become polarized and alter their functions to help the tumor proliferate and grow. It is now becoming more common to pair therapies together including immunotherapy with chemotherapy. Scientists are still trying to find ways to improve treatment and completely eradicate the tumor.

In San Francisco, California, a group of scientists, led by Dr. Alex Marson, are working to modify gene expression to reprogram or change immune cells in the TME to attack cancer. There has been some success, but this immunotherapy does not help treat all patients. In addition, the screening process to determine genetic changes to determine which cells would result in the greatest treatment efficacy is a long, arduous process. A group at the Gladstone Institutes has worked with Marson at University of California San Francisco (UCSF) to develop a strategy that helps pair different genetic combinations in a faster amount of time to determine the most beneficial treatment outcomes. This screening technique is called Pooled Knockin Screening (ModPoKI). ModPoKI finds the best genetic modifications to express in immune cells that will have prolonged anti-tumor efficacy.

The study that demonstrated ModPoKI was published recently in Cell, which demonstrates our ability to now understand how to combine genetic programs. ModPoKI combines genes into long lines of DNA to generate roughly 10,000 combinations to match with a genetically engineered immune cell known as a T cells are major immune cells that primarily target foreign antigens, like cancer cells, and kill them. Once the optimal gene modification is found, it is put into the engineered immune cells that are polarized to kill cancer. After further investigation, the combinations made by ModPoKI resulted in the most polarized anti-tumor T cells.

After years of anticipation and hard work by NASA’s OSIRIS-REx (Origins, Spectral Interpretation, Resource Identification and Security – Regolith Explorer) team, a capsule of rocks and dust collected from asteroid Bennu finally is on Earth. It landed at 8:52 a.m. MDT (10:52 a.m. EDT) on Sunday, in a targeted area of the Department of Defense’s Utah Test and Training Range near Salt Lake City.

Within an hour and a half, the capsule was transported by helicopter to a temporary clean room set up in a hangar on the training range, where it now is connected to a continuous flow of nitrogen.

Getting the sample under a “nitrogen purge,” as scientists call it, was one of the OSIRIS-REx team’s most critical tasks today. Nitrogen is a gas that doesn’t interact with most other chemicals, and a continuous flow of it into the sample container inside the capsule will keep out earthly contaminants to leave the sample pure for scientific analyses.

To make a gene-editing tool more precise and easier to control, Rice University engineers split it into two pieces that only come back together when a third small molecule is added.

Researchers in the lab of chemical and biomolecular engineer Xue Sherry Gao created a CRISPR-based gene editor designed to target adenine ⎯ one of the four main DNA building blocks ⎯ that remains inactive when disassembled but kicks into gear once the binding molecule is added.

Compared to the intact original, the split editor is more precise and stays active for a narrower window of time, which is important for avoiding off-target edits. Moreover, the activating small molecule used to bind the two pieces of the tool together is already being used as an anticancer and immunosuppressive drug.

Revolutionizing Musculoskeletal Health Through Microcapsule Drug Delivery — Dr. @George R. Dodge, Ph.D. — CEO & Co-Founder — Mechano-Therapeutics LLC

Dr. George R. Dodge, Ph.D. is CEO & Co-Founder of Mechano-Therapeutics LLC (https://mechano-therapeutics.com/), a biotechnology company spun out from his lab, and the labs of his partners Dr. Rob Mauck and Dr. Daeyeon Lee, at the University of Pennsylvania, specializing in microcapsule development using proprietary microfluidics for drug encapsulation, with a mission to revolutionize musculoskeletal health using an innovative platform technology to enhance delivery of therapeutics for improving patient outcomes.

Continue reading “Dr George Dodge — CEO & Co-Founder — Mechano-Therapeutics — Revolutionizing Musculoskeletal Health” »

It lets researchers extract pixel-by-pixel information from nanoscale.

The nanoscale refers to a length scale that is extremely small, typically on the order of nanometers (nm), which is one billionth of a meter. At this scale, materials and systems exhibit unique properties and behaviors that are different from those observed at larger length scales. The prefix “nano-” is derived from the Greek word “nanos,” which means “dwarf” or “very small.” Nanoscale phenomena are relevant to many fields, including materials science, chemistry, biology, and physics.